Jing Zhang
Huashan Hospital
8
8
4
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+5 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yuxian Huang
Huashan Hospital
Shared therapeutic areas:
Worked with same sponsors:
Lihang QI
Corxel Pharmaceuticals
Shared therapeutic areas:
Worked with same sponsors:
Yuewen XI
Huashan Hospital
Shared therapeutic areas:
Worked with same sponsors:
Xiangjun Chen
Huashan Hospital
Shared therapeutic areas:
Worked with same sponsors:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
General Manager
Tanabe Pharma Corporation
Shared therapeutic areas:
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Mark Hallett, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects
Drug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin
A Study of Etripamil in Healthy Subjects
Evaluate the Effect of TPN171H on the QT/QTc Interval in Healthy Volunteers
A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)
All 8 trials loaded